ArticleeLife2019
The impact of measles immunization campaigns in India using a nationally representative sample of 27,000 child deaths.
Article in eLife, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- A systematic review and modelling insights of factors impacting measles vaccine effectiveness, efficacy and immunogenicity.Discover viruses · 2025Review
- Analyzing the usage of theories of change for routine immunization programs -- a review of impact evaluations from LMICs.Journal of health, population, and nutrition · 2024Review
- Evaluating the impact of COVID-19 on routine childhood immunizations coverage in Zambia.PLOS global public health · 2024Article
- Interventions addressing routine childhood immunization and its behavioral and social drivers.Frontiers in public health · 2024Review
- Measles seroprevalence in persons over one year of age in Chandigarh, India.Human vaccines & immunotherapeutics · 2022Article
- Caregivers' Preferences of COVID-19 Vaccination for Children: A Cross-sectional Study From Rural South India.Medeniyet medical journal · 2022Article
- Socio-demographic correlates of first dose of measles (MCV1) vaccination coverage in India.BMC public health · 2020Article
- Seasonal variation and etiologic inferences of childhood pneumonia and diarrhea mortality in India.eLife · 2019Article
- Reducing measles mortality in India.eLife · 2019Article
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
Abstract
India comprises much of the persisting global childhood measles mortality. India implemented a mass second-dose measles immunization campaign in 2010. We used interrupted time series and multilevel regression to quantify the campaign's impact on measles mortality using the nationally representative Million Death Study (including 27,000 child deaths in 1.3 million households surveyed from 2005 to 2013). 1-59 month measles mortality rates fell more in the campaign states following launch (27%) versus non-campaign states (11%). Declines were steeper in girls than boys and were specific to measles deaths. Measles mortality risk was lower for children living in a campaign district (OR 0.6, 99% CI 0.4-0.8) or born in 2009 or later (OR 0.8, 99% CI 0.7-0.9). The campaign averted up to 41,000-56,000 deaths during 2010-13, or 39-57% of the expected deaths nationally. Elimination of measles deaths in India is feasible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.